Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Application History
40 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 23, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jul 23, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 27, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 25, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 25, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 25, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 19, 2023 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Sep 19, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 18, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 18, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Sep 15, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 7, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 7, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 7, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Sep 7, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Apr 17, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 17, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 17, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 3, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 1, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 1, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 1, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 10, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 8, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 8, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 8, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 8, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 11, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 11, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 22, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 9, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 8, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 8, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 8, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 8, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 6, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 21, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 17, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Classification
International Classes
042